Sware

Sware, Inc.

16 Investors
Regulatory Technology
CHELSEA, MA

Sware, Inc. is a regulatory technology company that specializes in tackling compliance challenges in the life sciences and healthcare sectors. Focusing primarily on 'validation debt,' Sware aims to streamline the compliance processes necessary for software systems in environments like pharmaceuticals, biotech, and medical devices.

Products & Team

Res_Q™

Validation PlatformSeed

Res_Q is a sophisticated validation platform crafted to automate and unify validation processes for regulated technologies. It serves as a vital tool for organizations in the life sciences sector to efficiently manage compliance.

Value Proposition

Res_Q tackles the problem of validation debt by minimizing reliance on outdated validation methods and enhancing efficiency.

Pain Points

These customers face challenges from cumbersome manual validation processes that lead to increased operational risks and hinder innovation.

Digitally maps validation processesAddresses Computer System Validation (CSV) and Computer Software Assurance (CSA)Substantially reduces time and resources for validation activitiesFacilitates a strategic, risk-based approach to compliance
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
CHELSEA, MA
Primary headquarters

Funding History

Total Raised:
$8.0M
E

Equity Offering

Closed
April 2024
$8.0M
Raised
Progress
100%
Raised
$8.0M
Target
$8.0M
#000181224425000002